tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PMVP Stock Latest News

PMV Pharmaceuticals Initiates Strategic Lease Termination
Company AnnouncementsPMV Pharmaceuticals Initiates Strategic Lease Termination
1M ago
8K
PMVP
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial
PremiumPress Releases
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial
1M ago
PMVP
PMV Pharmaceuticals sees cash runway to end of 2026
PremiumThe Fly
PMV Pharmaceuticals sees cash runway to end of 2026
1M ago
PMVP
PMV Pharmaceuticals says enrollment ‘on track’ for Phase 2 PYNNACLE trial
PremiumThe Fly
PMV Pharmaceuticals says enrollment ‘on track’ for Phase 2 PYNNACLE trial
1M ago
PMVP
PMV Pharmaceuticals reports Q2 EPS (2c), consensus (35c)
PremiumThe Fly
PMV Pharmaceuticals reports Q2 EPS (2c), consensus (35c)
1M ago
PMVP
PMV Pharmaceuticals, Foundation Medicine announce collaboration
PremiumThe FlyPMV Pharmaceuticals, Foundation Medicine announce collaboration
4M ago
PMVP
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
Premium
Press Releases
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
4M ago
PMVP
Craig-Hallum bullish on PMV Pharmaceuticals, initiates with a Buy
Premium
The Fly
Craig-Hallum bullish on PMV Pharmaceuticals, initiates with a Buy
4M ago
PMVP
PMV Pharmaceuticals initiated with a Buy at Craig-Hallum
PremiumThe Fly
PMV Pharmaceuticals initiated with a Buy at Craig-Hallum
4M ago
PMVP
PMV Pharmaceuticals sees cash runway to end of 2026
PremiumThe Fly
PMV Pharmaceuticals sees cash runway to end of 2026
4M ago
PMVP
PMV Pharmaceuticals reports Q1 EPS (30c), consensus (36c)
PremiumThe Fly
PMV Pharmaceuticals reports Q1 EPS (30c), consensus (36c)
4M ago
PMVP
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
PremiumPress Releases
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
4M ago
PMVP
PMV Pharmaceuticals initiated with a Buy at Jefferies
PremiumThe FlyPMV Pharmaceuticals initiated with a Buy at Jefferies
5M ago
PMVP
PMV Pharmaceuticals announces first patient dosed in Phase 2 PYNNACLE trial
Premium
The Fly
PMV Pharmaceuticals announces first patient dosed in Phase 2 PYNNACLE trial
6M ago
PMVP
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
Premium
Press Releases
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
6M ago
PMVP
PMV Pharmaceuticals reports promising efficacy of rezatapopt in OC study
PremiumThe Fly
PMV Pharmaceuticals reports promising efficacy of rezatapopt in OC study
6M ago
PMVP
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
PremiumPress Releases
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
6M ago
PMVP
PMV Pharmaceuticals reportsFY23 EPS ($1.44), consensus ($1.52)
PremiumThe Fly
PMV Pharmaceuticals reportsFY23 EPS ($1.44), consensus ($1.52)
7M ago
PMVP
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
PremiumPress Releases
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
7M ago
PMVP
PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
PremiumPress ReleasesPMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
7M ago
PMVP
PMV Pharmaceuticals annouces strategic 30% workforce reduction
Premium
The Fly
PMV Pharmaceuticals annouces strategic 30% workforce reduction
8M ago
PMVP
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
Premium
Press Releases
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
8M ago
PMVP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >